What is new?

Read all news items about the AGE Reader, Diab-spot and DiagnOptics.

MSP bodmann GmbH appointed as new distributor in Germany

Groningen, the Netherlands. June 29, 2017.

Diagnoptics announces that MSP bodmann GmbH (MSP) has been appointed as the new distributor of the AGE Reader in Germany for the pharmacies, general practitioners and diabetologists markets. 

MSP has been a successful player in the German diabetes market for over 15 years. Their main product is the GlucoSmart blood glucose measuring device. "Non-invasive technologies are pointing the way into the future of diagnostics - also for the early detection of risks of chronic diseases in the initial stage," explains Angela Bodmann, Managing Director of MSP bodmann GmbH. "With the innovative AGE-Reader, diabetologists as well as general practitioners are able to determine within a few seconds, the risk of diabetes or cardiovascular complications. The application is carried out by means of an optical measurement of the skin, without blood sampling and lengthy, cost-intensive laboratory tests", continues Angela Bodmann. Around 200 scientific studies have already proven the functionality of the AGE-Reader. "For all patients to be able to quickly make use of this painless, simple and fast method, we are striving to equip a nationwide and comprehensive range of diabetologists and general practitioners throughout Germany."

Diagnoptics was seeking a distribution partner after working on the clinical validation and business development itself for the last 5 years. Bart van den Berg, CEO of Diagnoptics: “We needed a partner that is capable of building on the business development work that we did and translate this into sales in the German diabetes market. We are extremely glad to establish this collaboration with a company that is well-connected in the diabetes world and a successful history like MSP. We are confident that this partnership with MSP we will be able to bring the AGE Reader to many more clinics in Germany and we are looking forward to working with them”.

The AGE Reader provides an immediate cardiovascular risk prediction in 12 seconds. The AGE Reader has been designed for patient friendly diagnosis and allows doctors to practice personalized care and prevent disease (progression). The method is convenient, easy to use and extensively validated.



Share this link on:

Latest news items

  1. AGE Reader product updates at EASD 2017 – Lisbon 2017
  2. MSP bodmann GmbH appointed as new distributor in Germany 2017
  3. New key publication: large scale study in metabolic syndrome 2017
  4. Diagnoptics appoints DiosPharma as the new Korean distributor 2016
  5. Visit Diagnoptics at the EASD congress 2016 in Munich 2016
  6. Selista appointed as new Japanese distributor for the AGE Reader mu 2016
  7. Diagnoptics bei dem DDG Kongress in Berlin 2016
  8. Diagnoptics receives Chinese market approval for AGE Reader SU 2016
  9. New patent granted to Diagnoptics in Japan and EU. 2016
  10. Diagnoptics receives Japanese market approval for AGE Reader mu. 2015
More Information
Request information

Would you like to learn more about our products? Request any information you wish to receive here.

AGE Reader mu
Non-invasive cardiovascular risk assessment
Age Reader MU
The AGE Reader mu is the next generation AGE Reader that combines a high measurement quality standard with an innovative design, at a reduced pricelevel. The AGE Reader mu is a perfect tool for diabetologists and family doctors.

Read more »
Newsletter subscription

If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.


Downloads about the AGE Reader and Diab-spot

About the company

Find information about Diagnoptics.

Information for patients

Find information about Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Find information about Advanced Glycation Endproducts, the AGE measurement and the clinical validation.